Clinical Trials Browser

INDUSTRY × Lymphoma, B-Cell × ibritumomab tiuxetan × Clear all

NCT00220285 2014-12-30

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell